InvestorsHub Logo

To infinity and beyond!

07/07/15 6:10 PM

#110428 RE: scottsmith #110419

SS: CTIX was competent enough to run a successful Phase 2 and it was a smashing success. Cannot imagine that Phase 3 will not be approved. Irrespective of any special designation Qidp etc I think everyone expects Brilacidin to move forward, and to be successful. The larger question is when and if offers for Brilacidin will be entertained. Only for B? What about B OM for mucositis and for Gi use? It is complicated and those decisions will move the share price- eventually.

Do you and others really expect Brilacidin not to make it to market?

I know zippo about any meeting.

Would be interested in hearing about progress on 1502- if there is any